Alpha DNA Investment Management’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-10
Closed -$1K – 630
2021
Q1
$1K Sell
10
-36
-78% -$4.48K ﹤0.01% 657
2020
Q4
$5K Buy
+46
New +$4.64K 0.01% 380

Other funds holding USPH

Alpha DNA Investment Management's USPH Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of US Physical Therapy (USPH) in Q2 2021, closing a stake of 10 shares — an estimated $1K sold.

Alpha DNA Investment Management first reported a position in USPH in Q4 2020 and held it in 2 quarters. The position peaked at $5K in Q4 2020. 219 funds tracked by Wall St. Rank hold USPH as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining US Physical Therapy position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 10 US Physical Therapy shares in Q2 2021, an estimated $1K.
  • Alpha DNA Investment Management first reported a position in US Physical Therapy in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's US Physical Therapy position peaked at $5K in Q4 2020.
  • 219 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.